尿酸在帕金森氏症模型中调节α-synuclein传输
Yu Jin Shin1,2, Yeon Ju Kim1,2, Ji Eun Lee1,2
1Department of Neurology, Yonsei University College of Medicine, Seoul, Republic of Korea.
Frontiers in aging neuroscience
|September 15, 2023
概括
尿酸 (UA) 在帕金森病模型中降低了α-syn (α-syn) 的扩散. 这种抗氧化剂通过抑制α-syn内部化和细胞间传播来保护关键的神经元.
科学领域:
- 神经科学是一个神经科学.
- 生物化学 生物化学
- 病理学 病理学 病理学
背景情况:
- 阿尔法-同核素 (α-syn) 聚合和传播是帕金森病 (PD) 病原体的核心.
- 尿酸 (UA) 是一种强大的内源性抗氧化剂,目前正在研究其在PD中的神经保护潜力.
研究的目的:
- 调查UA治疗对细胞外α-syn细胞间细胞间传播的影响.
- 为了确定UA是否在α-syn诱导的PD模型中保护多巴氨基神经元.
主要方法:
- 利用细胞模型 (捐赠者-接受者细胞) 来评估α-syn内部化和细胞间转移.
- 使用α-syn-inoculated小鼠来评估UA对α-syn传播和神经元存活的影响.
- 监测自和微质活动的标志物.
主要成果:
- 在细胞模型中,UA治疗显著降低了细胞内α-syn水平和神经元对神经元α-syn传输.
- 在小鼠中服用UA抑制了细胞外α-syn的传播,减少了 substantia nigra多巴胺作用神经元中的酸化α-syn.
- UA治疗导致多巴氨基神经元的存活率增加,而不会改变自酶体或微质标记物.
结论:
- 尿酸通过抑制胺介导和克拉介导的内细胞分裂来调节α-syn的传播.
- 在PD模型中,UA通过减少α-syn扩散和增强多巴胺类神经元存活来证明神经保护作用.
- 通过针对α-syn病理的多方面的机制,UA可能代表帕金森病的治疗策略.
更多相关视频
14:45Analyzing the Parkinson's Disease Mouse Model Induced by Adeno-associated Viral Vectors Encoding Human α-Synuclein
Published on: July 29, 2022
6.0K
06:07Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease
Published on: June 23, 2023
1.6K
相关概念视频
Neural Regulation
39.5K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.5K
Parkinson's Disease: Overview
592
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
592
Lysosomal Hydrolases
3.8K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.8K
Parkinson's Disease: Treatment
295
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
295
